Bicycle Therapeutics BCYC Income Statement (2018-2026)

NASDAQ BCYC
$4.28 +0.04 (+0.94%)
As of: Sep 4, 2026 · 11:47 AM EDT
Reported Financials

Bicycle Therapeutics Quarterly Income Statement

Periods 34 quarters
Latest Jun 2026

Bicycle Therapeutics reported revenue of $0.63M and net income of -$50.47M for the quarter ended Jun 2026, down 78.5% year over year. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
25.60M41.42M41.42M41.42M41.42M41.42M41.42M41.42M42.38M42.43M42.63M68.99M69.02M69.06M69.20M69.25M69.31M69.37M69.71M69.81M
Revenue & cost
Revenue
4.33M1.60M3.86M8.40M3.04M8.40M4.90M11.40M5.35M5.33M19.53M9.36M2.68M3.71M9.98M2.92M11.73M47.95M0.89M0.63M
Operating items
Research & DevelopmentR&D
10.51M12.96M14.28M19.85M22.75M24.72M32.21M39.72M39.87M44.70M34.86M40.06M48.27M49.78M59.06M71.03M58.43M51.77M48.90M41.16M
Wages, Salaries and OtherWages
5.72M5.53M5.84M6.42M7.05M7.06M7.30M6.95M7.66M5.61M
Selling, General & AdministrativeSG&A
8.11M8.84M16.96M11.82M10.05M10.68M14.49M14.79M16.28M14.87M16.38M15.95M18.26M21.59M21.12M18.49M18.86M20.89M17.47M14.03M
Restructuring CostsRestructuring
2.02M1.92M2.53M2.58M2.19M2.33M2.47M2.58M2.54M1.97M
Other Operating ExpensesOther Opex
-2.02M-1.92M-2.53M-2.58M-2.19M-2.33M-2.47M-2.58M-2.54M-1.97M
Operating ExpensesOpex
18.63M21.80M31.24M31.68M32.80M35.40M46.70M54.51M56.15M59.57M51.25M56.01M66.52M71.37M80.18M89.52M77.28M72.66M66.37M55.19M
Operating IncomeOp. Inc
-14.29M-18.02M-27.38M-27.30M-29.76M-32.21M-41.80M-43.11M-50.80M-54.23M-31.72M-46.65M-63.85M-67.66M-70.20M-86.60M-65.55M-24.71M-65.48M-54.56M
EBIT
-14.29M-18.02M-27.38M-27.30M-29.76M-32.21M-41.80M-43.11M-50.80M-54.23M-31.72M-46.65M-63.85M-67.66M-70.20M-86.60M-65.55M-24.71M-65.48M-54.56M
Non-operating items
Non Operating Interest Expenses
0.82M0.82M0.82M0.88M0.82M0.83M0.81M0.82M0.81M0.82M0.82M0.82M0.03M0.05M0.05M0.05M0.04M0.06M0.05M0.04M
Interest & Investment IncomeInt & Inv Inc
0.02M0.06M0.22M0.91M1.99M2.64M2.93M0.81M3.98M6.28M5.62M7.77M10.58M10.30M8.41M7.47M6.70M5.88M4.88M4.36M
Other Non Operating IncomeOther Non Op Inc.
0.07M0.10M-1.00M-0.20M0.74M0.16M13.19M0.11M0.07M
Non Operating IncomeNon Op. Inc.
-0.80M-0.76M-0.60M0.03M1.17M1.81M2.12M-0.01M3.17M5.46M4.80M6.95M9.60M14.73M8.36M7.42M6.66M5.82M4.83M4.32M
Net income details
EBT
-15.09M-19.85M-27.98M-27.27M-28.59M-32.43M-39.68M-43.12M-47.63M-52.55M-26.91M-39.70M-54.25M-58.75M-61.84M-79.18M-58.90M-25.54M-60.65M-50.24M
Tax ProvisionsTaxes
-0.41M-0.79M-0.42M-0.45M-0.24M4.56M-0.62M-0.52M2.30M-2.99M-0.40M0.12M-3.45M-1.10M-1.10M-0.23M0.20M-53.59M0.20M0.10M
Profit After TaxPAT
-14.70M-18.21M-27.56M-26.83M-28.35M-29.98M-39.06M-42.60M-49.90M-50.76M-26.56M-39.81M-52.90M-49.97M-60.75M-80.85M-59.21M-20.19M-60.83M-50.47M
Income from Continuing OperationsIncome (Continuing)
-14.68M-19.06M-27.56M-26.83M-28.35M-36.99M-39.06M-42.60M-49.93M-49.57M-26.51M-39.81M-50.80M-57.65M-60.74M-78.95M-59.10M28.05M-60.85M-50.34M
Consolidated Net IncomeConsol Net Inc.
-14.68M-19.06M-27.56M-26.83M-28.35M-36.99M-39.06M-42.60M-49.93M-49.57M-26.51M-39.81M-50.80M-57.65M-60.74M-78.95M-59.10M28.05M-60.85M-50.34M
Income towards Parent CompanyParent Net Inc
-14.68M-19.06M-27.56M-26.83M-28.35M-36.99M-39.06M-42.60M-49.93M-49.57M-26.51M-39.81M-50.80M-57.65M-60.74M-78.95M-59.10M28.05M-60.85M-50.34M
Net Income towards Common StockholdersNet Income
-14.68M-18.04M-27.56M-26.83M-28.35M-29.98M-39.06M-42.60M-49.90M-49.10M-26.56M-39.81M-50.80M-51.85M-60.75M-78.95M-59.10M-20.15M-60.83M-50.33M
Additional items
EPS (Basic)
-0.59-0.72-0.93-0.90-0.96-1.01-1.30-1.41-1.26-1.38-0.62-0.77-0.74-0.89-0.88-1.14-0.85-0.29-0.87-0.72
EPS (Diluted)
-0.59-0.72-0.93-0.90-0.96-1.01-1.30-1.41-1.26-1.38-0.62-0.77-0.74-0.89-0.88-1.14-0.85-0.29-0.87-0.72
Shares Outstanding
25.04M25.06M29.61M29.65M29.68M29.66M30.00M30.19M39.58M35.59M42.56M51.99M68.99M58.21M69.20M69.25M69.30M69.28M69.68M69.80M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
25.04M25.06M29.61M29.65M29.68M29.66M30.00M30.19M39.58M35.59M42.56M51.99M68.99M58.21M69.20M69.25M69.30M69.28M69.68M69.80M
EBITDA
-14.29M-18.02M-27.38M-27.30M-29.76M-32.21M-41.80M-43.11M-50.80M-54.23M-31.72M-46.65M-63.85M-67.66M-70.20M-86.60M-65.55M-24.71M-65.48M-54.56M
Interest ExpensesInt Expense
0.82M0.82M0.82M0.88M0.82M0.83M0.81M0.82M0.81M0.82M0.82M0.82M0.03M0.05M0.05M0.05M0.04M0.06M0.05M0.04M
Tax Rate
2.753.951.501.640.83-14.051.561.20-4.835.681.49-0.296.361.871.780.29-0.35209.85-0.33-0.20